Advertisement

We need your help now

Support from readers like you keeps The Journal open.

You are visiting us because we have something you value. Independent, unbiased news that tells the truth. Advertising revenue goes some way to support our mission, but this year it has not been enough.

If you've seen value in our reporting, please contribute what you can, so we can continue to produce accurate and meaningful journalism. For everyone who needs it.

File photo Sasko Lazarov/Photocall Ireland

US medical products company to create 50 new jobs

The jobs will be created over the next three years with the backing of the IDA.

A US MEDICAL products company has announced that it is to create 50 new jobs with the help of the IDA over the next three years.

ResMed, which manufactures products to combat sleep and respiratory disorders, has announced that it is expand its research and development facility in Dublin over the next three years.

Its current centre is based at a facility at University College Dublin and assists companies to access the university’s research base.

The company says that the new jobs will facilitate the development of sensor-based technology designed for patients with chronic diseases in their home.

“We believe there are great opportunities in growing our presence in Ireland,” ResMed founder, chairman and chief executive Dr Peter Farrell said.

“One of the factors that played a part in our 2011 acquisition of BiancaMed, a UCD spin-out company, was the tremendous advantage of being based in a country that strongly supports research and development.”

Readers like you are keeping these stories free for everyone...
A mix of advertising and supporting contributions helps keep paywalls away from valuable information like this article. Over 5,000 readers like you have already stepped up and support us with a monthly payment or a once-off donation.

Close
6 Comments
    Submit a report
    Please help us understand how this comment violates our community guidelines.
    Thank you for the feedback
    Your feedback has been sent to our team for review.
    JournalTv
    News in 60 seconds